The goal of this clinical trial is to assess the effectiveness of oral iohexol in the treatment of postoperative chylous ascites. It will also learn about the safety of oral iohexol. The main questions it aims to answer are: * Confirm the potential of oral iohexol as an innovative therapeutic regimen. * Confirm its ability to improve clinical outcomes for patients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
grading system for efficacy of iohexol intervention
Timeframe: up to 3 weeks after the intervention